

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.40081242 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.40081242 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.40081242 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.40081242 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.40081242 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.40081242 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.86740165 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.78029878 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.53174426 |
| 10 | response to peptidoglycan (GO:0032494) | 5.20411691 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19240790 |
| 12 | microglial cell activation (GO:0001774) | 5.12227623 |
| 13 | detection of other organism (GO:0098543) | 4.93350933 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.90067503 |
| 15 | response to host immune response (GO:0052572) | 4.90067503 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.89273765 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.86331454 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.69077108 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.61273998 |
| 20 | detection of bacterium (GO:0016045) | 4.61057440 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.51991136 |
| 22 | response to host defenses (GO:0052200) | 4.49738457 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.49738457 |
| 24 | response to host (GO:0075136) | 4.49738457 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.45335006 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 4.12577607 |
| 27 | regulation of mast cell degranulation (GO:0043304) | 4.12250018 |
| 28 | cellular extravasation (GO:0045123) | 4.10711882 |
| 29 | regulation of mononuclear cell migration (GO:0071675) | 4.09137792 |
| 30 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.06216770 |
| 31 | detection of biotic stimulus (GO:0009595) | 4.01777932 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.99382327 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.97837769 |
| 34 | * respiratory burst (GO:0045730) | 3.96369215 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.90513791 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.90507394 |
| 37 | granulocyte activation (GO:0036230) | 3.88312246 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.87068473 |
| 39 | negative regulation of mast cell activation (GO:0033004) | 3.85150414 |
| 40 | * macrophage activation (GO:0042116) | 3.83156944 |
| 41 | neutrophil activation (GO:0042119) | 3.82435635 |
| 42 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.76262995 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.72570325 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72283598 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.71040759 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.70303384 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.70303384 |
| 48 | pinocytosis (GO:0006907) | 3.67792658 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62311389 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59906131 |
| 51 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.59150271 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58869896 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56031395 |
| 54 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.50513022 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.46411855 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.45923932 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.45289684 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 3.40604275 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.39254399 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37574309 |
| 61 | negative regulation of cell killing (GO:0031342) | 3.37574309 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 3.37386754 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.37285491 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35959930 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.34670446 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 3.32193461 |
| 67 | regulation of cholesterol storage (GO:0010885) | 3.30999234 |
| 68 | superoxide anion generation (GO:0042554) | 3.29299952 |
| 69 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.27367442 |
| 70 | neutrophil chemotaxis (GO:0030593) | 3.27171122 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 3.22955863 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22855519 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.21225424 |
| 74 | leukocyte aggregation (GO:0070486) | 3.21138619 |
| 75 | low-density lipoprotein particle clearance (GO:0034383) | 3.21134970 |
| 76 | leukocyte degranulation (GO:0043299) | 3.19484149 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18939558 |
| 78 | B cell mediated immunity (GO:0019724) | 3.18289413 |
| 79 | neutrophil migration (GO:1990266) | 3.17665768 |
| 80 | negative regulation of interleukin-1 production (GO:0032692) | 3.17282020 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.17123498 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17108197 |
| 83 | reactive oxygen species biosynthetic process (GO:1903409) | 3.14508782 |
| 84 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13780220 |
| 85 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13780220 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 3.12691561 |
| 87 | response to interleukin-15 (GO:0070672) | 3.12216461 |
| 88 | * positive regulation of antigen processing and presentation (GO:0002579) | 3.12044754 |
| 89 | germinal center formation (GO:0002467) | 3.11797198 |
| 90 | negative regulation of granulocyte differentiation (GO:0030853) | 3.11040431 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 3.10853637 |
| 92 | regulation of macrophage chemotaxis (GO:0010758) | 3.10750749 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09503949 |
| 94 | negative regulation of interleukin-6 production (GO:0032715) | 3.09186526 |
| 95 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.08499664 |
| 96 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08210433 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.08096681 |
| 98 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.05442249 |
| 99 | lymphocyte chemotaxis (GO:0048247) | 3.01668160 |
| 100 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.00635814 |
| 101 | positive regulation of B cell differentiation (GO:0045579) | 3.00231317 |
| 102 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99905137 |
| 103 | T-helper 1 type immune response (GO:0042088) | 2.98164848 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97519220 |
| 105 | negative regulation of innate immune response (GO:0045824) | 2.97487733 |
| 106 | mannose metabolic process (GO:0006013) | 2.94275033 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94136745 |
| 108 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.93717709 |
| 109 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93670089 |
| 110 | granulocyte chemotaxis (GO:0071621) | 2.92592581 |
| 111 | apoptotic cell clearance (GO:0043277) | 2.91208771 |
| 112 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.89236744 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.87713793 |
| 114 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86422434 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.86400804 |
| 116 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85281268 |
| 117 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85281268 |
| 118 | granulocyte migration (GO:0097530) | 2.84104775 |
| 119 | activated T cell proliferation (GO:0050798) | 2.83544637 |
| 120 | positive regulation of chemokine production (GO:0032722) | 2.82599811 |
| 121 | * myeloid leukocyte activation (GO:0002274) | 2.81613998 |
| 122 | regulation of integrin activation (GO:0033623) | 2.80820341 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 2.79273749 |
| 124 | cellular response to interleukin-15 (GO:0071350) | 2.79192010 |
| 125 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78676799 |
| 126 | cellular response to type I interferon (GO:0071357) | 2.78160967 |
| 127 | type I interferon signaling pathway (GO:0060337) | 2.78160967 |
| 128 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76856230 |
| 129 | response to type I interferon (GO:0034340) | 2.75433439 |
| 130 | hyaluronan catabolic process (GO:0030214) | 2.74893509 |
| 131 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.74598855 |
| 132 | natural killer cell mediated immunity (GO:0002228) | 2.74598855 |
| 133 | * regulation of antigen processing and presentation (GO:0002577) | 2.74181058 |
| 134 | regulation of chemokine biosynthetic process (GO:0045073) | 2.73842324 |
| 135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.73775720 |
| 136 | leukocyte mediated cytotoxicity (GO:0001909) | 2.73275862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.28481224 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.97091365 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55528871 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.96125376 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.76739495 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.09416642 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.01844888 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47185237 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.22324531 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.14475367 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14256065 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.96023469 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71598692 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60192467 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.59850847 |
| 16 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.55282640 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55070236 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49367659 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.39116101 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31096619 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29385622 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18550463 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.16226490 |
| 24 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99665025 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95711040 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93532162 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93321916 |
| 28 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87049117 |
| 29 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.86953794 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86687216 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82921467 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81347753 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74101206 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71333461 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71230605 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.70536275 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70219161 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68343833 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63069015 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61722372 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60618830 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57195668 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.51578989 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49515252 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48985622 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48282653 |
| 47 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48040962 |
| 48 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46865330 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.46779038 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43606968 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41426436 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38138001 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34963633 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28890576 |
| 55 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27740099 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25884899 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25011177 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.24029222 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24003589 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22515042 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16976875 |
| 62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15861647 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15054398 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14367035 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13756579 |
| 66 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.13713384 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12637019 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10639323 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09424013 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07719000 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06499812 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05660398 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04724764 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04454726 |
| 75 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02896088 |
| 76 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01012603 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97369692 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96914332 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96735749 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95319895 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92380368 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91524981 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90201606 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89641075 |
| 85 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.89639297 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89606375 |
| 87 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89017012 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.88646056 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87828035 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86350680 |
| 91 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.86232101 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 0.85186637 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84249575 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 0.83634207 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83541750 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82931868 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81332536 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80488259 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80451254 |
| 100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79139848 |
| 101 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.76214650 |
| 102 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75268058 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74364224 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.71905487 |
| 105 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71754581 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.71705311 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.71334176 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70948027 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66563971 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65472644 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64445643 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64445643 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64389750 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.63114707 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62926971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.49859936 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.09285838 |
| 3 | MP0003436_decreased_susceptibility_to | 3.92826536 |
| 4 | MP0003303_peritoneal_inflammation | 3.92116210 |
| 5 | MP0006082_CNS_inflammation | 3.46060312 |
| 6 | MP0002419_abnormal_innate_immunity | 3.27198828 |
| 7 | MP0009840_abnormal_foam_cell | 3.11704298 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.03021951 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.88836926 |
| 10 | MP0009785_altered_susceptibility_to | 2.87929033 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.84058090 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.69462178 |
| 13 | * MP0005025_abnormal_response_to | 2.61214455 |
| 14 | MP0001790_abnormal_immune_system | 2.53708938 |
| 15 | MP0005387_immune_system_phenotype | 2.53708938 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.48042858 |
| 17 | MP0004510_myositis | 2.40750468 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.37065627 |
| 19 | MP0003724_increased_susceptibility_to | 2.34463401 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.32103809 |
| 21 | MP0001800_abnormal_humoral_immune | 2.25107798 |
| 22 | MP0002723_abnormal_immune_serum | 2.18410543 |
| 23 | MP0000343_altered_response_to | 2.14314818 |
| 24 | MP0005671_abnormal_response_to | 2.09666805 |
| 25 | MP0000685_abnormal_immune_system | 2.02746999 |
| 26 | MP0003075_altered_response_to | 2.02690619 |
| 27 | MP0001819_abnormal_immune_cell | 2.00829161 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.98394512 |
| 29 | MP0002405_respiratory_system_inflammati | 1.92229959 |
| 30 | MP0003690_abnormal_glial_cell | 1.84878986 |
| 31 | MP0000604_amyloidosis | 1.84019024 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.79386584 |
| 33 | MP0004947_skin_inflammation | 1.77012292 |
| 34 | MP0009278_abnormal_bone_marrow | 1.71553359 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.68849406 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.67287375 |
| 37 | MP0008469_abnormal_protein_level | 1.63790472 |
| 38 | MP0003448_altered_tumor_morphology | 1.60114708 |
| 39 | MP0001853_heart_inflammation | 1.59783848 |
| 40 | MP0009764_decreased_sensitivity_to | 1.55413778 |
| 41 | MP0002132_abnormal_respiratory_system | 1.51902863 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.47330613 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.42774475 |
| 44 | MP0005451_abnormal_body_composition | 1.41037720 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.40865503 |
| 46 | MP0000716_abnormal_immune_system | 1.40577119 |
| 47 | MP0005166_decreased_susceptibility_to | 1.38043904 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.35677033 |
| 49 | MP0005310_abnormal_salivary_gland | 1.31934809 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.30858757 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.29726915 |
| 52 | MP0001851_eye_inflammation | 1.29295699 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.27901285 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.25151359 |
| 55 | MP0002933_joint_inflammation | 1.24586779 |
| 56 | MP0002398_abnormal_bone_marrow | 1.20698694 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.14899014 |
| 58 | MP0000858_altered_metastatic_potential | 1.14146047 |
| 59 | MP0010307_abnormal_tumor_latency | 1.14101584 |
| 60 | MP0003866_abnormal_defecation | 1.13768561 |
| 61 | MP0002429_abnormal_blood_cell | 1.13755210 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.12670472 |
| 63 | MP0008004_abnormal_stomach_pH | 1.11870449 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.11731767 |
| 65 | MP0005390_skeleton_phenotype | 1.09040785 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.07190210 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.07190210 |
| 68 | MP0002722_abnormal_immune_system | 1.05011956 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.04463631 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.04000270 |
| 71 | MP0004381_abnormal_hair_follicle | 1.03065704 |
| 72 | MP0005164_abnormal_response_to | 1.01791169 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.01767671 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.01309749 |
| 75 | MP0003828_pulmonary_edema | 1.00092668 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.98095063 |
| 77 | MP0008260_abnormal_autophagy | 0.97475456 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.96338357 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.95200248 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.94958369 |
| 81 | MP0009763_increased_sensitivity_to | 0.94359091 |
| 82 | MP0002006_tumorigenesis | 0.93611075 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.93298882 |
| 84 | MP0000249_abnormal_blood_vessel | 0.89392679 |
| 85 | MP0005023_abnormal_wound_healing | 0.84383440 |
| 86 | MP0002254_reproductive_system_inflammat | 0.83828666 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.81527592 |
| 88 | MP0003186_abnormal_redox_activity | 0.80166478 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.80121494 |
| 90 | MP0004883_abnormal_blood_vessel | 0.78308347 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.77065238 |
| 92 | MP0000371_diluted_coat_color | 0.76675208 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.73925237 |
| 94 | MP0004858_abnormal_nervous_system | 0.71988947 |
| 95 | MP0000609_abnormal_liver_physiology | 0.71951758 |
| 96 | MP0003795_abnormal_bone_structure | 0.69325615 |
| 97 | MP0002090_abnormal_vision | 0.69025965 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.68575146 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.66182624 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.66057243 |
| 101 | MP0000920_abnormal_myelination | 0.65222856 |
| 102 | MP0003045_fibrosis | 0.65013835 |
| 103 | MP0001873_stomach_inflammation | 0.65008092 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.63381426 |
| 105 | MP0008874_decreased_physiological_sensi | 0.62458753 |
| 106 | MP0001958_emphysema | 0.61409443 |
| 107 | MP0003279_aneurysm | 0.61013783 |
| 108 | MP0004130_abnormal_muscle_cell | 0.60991400 |
| 109 | MP0001663_abnormal_digestive_system | 0.60694102 |
| 110 | MP0003329_amyloid_beta_deposits | 0.59654234 |
| 111 | MP0006054_spinal_hemorrhage | 0.59602375 |
| 112 | MP0001915_intracranial_hemorrhage | 0.59525520 |
| 113 | MP0003195_calcinosis | 0.59278135 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.57415257 |
| 115 | MP0003878_abnormal_ear_physiology | 0.57415257 |
| 116 | MP0003091_abnormal_cell_migration | 0.57366211 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.56836955 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.55818026 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.55739648 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.51369605 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.49363954 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.48860937 |
| 123 | MP0002133_abnormal_respiratory_system | 0.47984951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.12358626 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 7.08241558 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 6.32750081 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.13101883 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.02345694 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.90900399 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.65580077 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 5.49687669 |
| 9 | Glomerulonephritis (HP:0000099) | 5.27125245 |
| 10 | Abnormality of macrophages (HP:0004311) | 5.10163488 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.72524260 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.72524260 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.72524260 |
| 14 | Dysostosis multiplex (HP:0000943) | 4.57371586 |
| 15 | Complement deficiency (HP:0004431) | 3.98628259 |
| 16 | Axonal loss (HP:0003447) | 3.97277469 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.80744381 |
| 18 | Abnormality of complement system (HP:0005339) | 3.80680770 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 3.78640662 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.76589945 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.72930745 |
| 22 | Obstructive lung disease (HP:0006536) | 3.72930745 |
| 23 | Disinhibition (HP:0000734) | 3.71825816 |
| 24 | Gingivitis (HP:0000230) | 3.70826711 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.67385215 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.67385215 |
| 27 | Loss of speech (HP:0002371) | 3.58971316 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.56751891 |
| 29 | Encephalitis (HP:0002383) | 3.51640907 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.51018872 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.51018872 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.51018872 |
| 33 | Recurrent skin infections (HP:0001581) | 3.51005866 |
| 34 | Myositis (HP:0100614) | 3.50182241 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38047681 |
| 36 | Orchitis (HP:0100796) | 3.35269433 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.28812770 |
| 38 | Hemoptysis (HP:0002105) | 3.24536821 |
| 39 | Stomatitis (HP:0010280) | 3.20681809 |
| 40 | Nephritis (HP:0000123) | 3.18508035 |
| 41 | Episodic fever (HP:0001954) | 3.15699854 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12617245 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 3.11221777 |
| 44 | Increased IgE level (HP:0003212) | 3.08270507 |
| 45 | Agnosia (HP:0010524) | 3.03804487 |
| 46 | Spontaneous hematomas (HP:0007420) | 3.00267768 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.97649240 |
| 48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90519990 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.89884873 |
| 50 | Myocardial infarction (HP:0001658) | 2.88397088 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.87674789 |
| 52 | Pustule (HP:0200039) | 2.84899536 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.82401004 |
| 54 | Optic neuritis (HP:0100653) | 2.82401004 |
| 55 | Chest pain (HP:0100749) | 2.80680285 |
| 56 | Urticaria (HP:0001025) | 2.75647554 |
| 57 | Anorexia (HP:0002039) | 2.71788620 |
| 58 | Upper motor neuron abnormality (HP:0002127) | 2.71651955 |
| 59 | Hematochezia (HP:0002573) | 2.71017016 |
| 60 | Prostate neoplasm (HP:0100787) | 2.65888850 |
| 61 | T lymphocytopenia (HP:0005403) | 2.62252989 |
| 62 | Pulmonary embolism (HP:0002204) | 2.58837337 |
| 63 | Cellulitis (HP:0100658) | 2.58788173 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.54353406 |
| 65 | Pathologic fracture (HP:0002756) | 2.52230308 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.51628206 |
| 67 | Hypochromic anemia (HP:0001931) | 2.50980467 |
| 68 | Epistaxis (HP:0000421) | 2.48821083 |
| 69 | Periodontitis (HP:0000704) | 2.48601074 |
| 70 | Peritonitis (HP:0002586) | 2.44848912 |
| 71 | Basal ganglia calcification (HP:0002135) | 2.44451529 |
| 72 | Thick nail (HP:0001805) | 2.43880919 |
| 73 | J-shaped sella turcica (HP:0002680) | 2.42183804 |
| 74 | Recurrent viral infections (HP:0004429) | 2.41135366 |
| 75 | Gangrene (HP:0100758) | 2.38731070 |
| 76 | Purpura (HP:0000979) | 2.37972650 |
| 77 | Vasculitis (HP:0002633) | 2.35449296 |
| 78 | Amyloidosis (HP:0011034) | 2.33659782 |
| 79 | Osteomyelitis (HP:0002754) | 2.31898808 |
| 80 | Chronic otitis media (HP:0000389) | 2.28919354 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.28609346 |
| 82 | Increased IgM level (HP:0003496) | 2.28283583 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.26229050 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.23103296 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22667041 |
| 86 | Joint hemorrhage (HP:0005261) | 2.19736045 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 2.19000536 |
| 88 | Abnormality of the endocardium (HP:0004306) | 2.16198982 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.15518077 |
| 90 | Abnormality of T cells (HP:0002843) | 2.15303469 |
| 91 | Meningitis (HP:0001287) | 2.15107325 |
| 92 | Vertigo (HP:0002321) | 2.14900246 |
| 93 | Leukocytosis (HP:0001974) | 2.14177693 |
| 94 | Polyneuropathy (HP:0001271) | 2.13294518 |
| 95 | Progressive visual loss (HP:0000529) | 2.12679286 |
| 96 | Bone pain (HP:0002653) | 2.11336470 |
| 97 | Panhypogammaglobulinemia (HP:0003139) | 2.09794498 |
| 98 | Recurrent pneumonia (HP:0006532) | 2.09349974 |
| 99 | Premature loss of primary teeth (HP:0006323) | 2.08619624 |
| 100 | Peripheral demyelination (HP:0011096) | 2.06408072 |
| 101 | Sepsis (HP:0100806) | 2.05846051 |
| 102 | Acne (HP:0001061) | 2.05675156 |
| 103 | Conjunctival telangiectasia (HP:0000524) | 2.05571711 |
| 104 | Colitis (HP:0002583) | 2.03764510 |
| 105 | Granulocytopenia (HP:0001913) | 2.01438575 |
| 106 | Gingival bleeding (HP:0000225) | 2.00643574 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98530467 |
| 108 | Inflammation of the large intestine (HP:0002037) | 1.98436826 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 1.97508168 |
| 110 | Tetraparesis (HP:0002273) | 1.97396748 |
| 111 | Spondylolisthesis (HP:0003302) | 1.97018092 |
| 112 | Glomerulopathy (HP:0100820) | 1.96792760 |
| 113 | Arterial thrombosis (HP:0004420) | 1.96239772 |
| 114 | Cheilitis (HP:0100825) | 1.95635781 |
| 115 | Keratitis (HP:0000491) | 1.94733828 |
| 116 | Petechiae (HP:0000967) | 1.94653061 |
| 117 | Abnormality of the lumbar spine (HP:0100712) | 1.94429917 |
| 118 | Microcytic anemia (HP:0001935) | 1.92840250 |
| 119 | Abnormality of the pericardium (HP:0001697) | 1.90796237 |
| 120 | Increased serum ferritin (HP:0003281) | 1.89924319 |
| 121 | Abnormality of the peritoneum (HP:0002585) | 1.89475900 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89309755 |
| 123 | Osteolytic defects of the hand bones (HP:0009699) | 1.89309755 |
| 124 | Lymphopenia (HP:0001888) | 1.89140489 |
| 125 | Malnutrition (HP:0004395) | 1.88279598 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 1.87933029 |
| 127 | Global brain atrophy (HP:0002283) | 1.87320413 |
| 128 | Diminished motivation (HP:0000745) | 1.87204720 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.85191158 |
| 130 | Apathy (HP:0000741) | 1.84933005 |
| 131 | Mutism (HP:0002300) | 1.84321082 |
| 132 | Retinal atrophy (HP:0001105) | 1.84252444 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83119335 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83119335 |
| 135 | Deformed sella turcica (HP:0002681) | 1.82458120 |
| 136 | Nasal polyposis (HP:0100582) | 1.82285970 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.82194567 |
| 138 | Inappropriate behavior (HP:0000719) | 1.81701470 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.81423173 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.79828220 |
| 141 | Gastrointestinal inflammation (HP:0004386) | 1.79540965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.87152029 |
| 2 | TBK1 | 3.44346919 |
| 3 | MAP3K14 | 3.38845257 |
| 4 | IRAK4 | 3.31681161 |
| 5 | TYK2 | 3.31040424 |
| 6 | RIPK4 | 3.22638420 |
| 7 | IRAK3 | 3.16044118 |
| 8 | TGFBR2 | 3.13197798 |
| 9 | ERN1 | 3.08995084 |
| 10 | KIT | 2.96092216 |
| 11 | MAP4K1 | 2.61922539 |
| 12 | TNK2 | 2.37099612 |
| 13 | IKBKE | 2.20712402 |
| 14 | CSF1R | 2.19237198 |
| 15 | TAOK1 | 1.93577496 |
| 16 | FGR | 1.92004137 |
| 17 | IKBKB | 1.91813823 |
| 18 | CSK | 1.91336626 |
| 19 | ZAP70 | 1.72341719 |
| 20 | EPHB1 | 1.70863606 |
| 21 | TXK | 1.70023899 |
| 22 | FES | 1.70013308 |
| 23 | JAK1 | 1.68053871 |
| 24 | CAMK1D | 1.66396394 |
| 25 | HCK | 1.65565928 |
| 26 | PRPF4B | 1.57708866 |
| 27 | PBK | 1.57368566 |
| 28 | SYK | 1.47065755 |
| 29 | GRK7 | 1.41672922 |
| 30 | JAK3 | 1.37918321 |
| 31 | TAOK3 | 1.36188343 |
| 32 | BTK | 1.34866337 |
| 33 | STK10 | 1.34809448 |
| 34 | LYN | 1.34480698 |
| 35 | CLK1 | 1.29767803 |
| 36 | IRAK1 | 1.26519348 |
| 37 | MATK | 1.26432205 |
| 38 | NEK9 | 1.24346137 |
| 39 | LCK | 1.18005437 |
| 40 | MAP2K3 | 1.15138838 |
| 41 | KSR2 | 1.11443888 |
| 42 | PKN2 | 1.11222744 |
| 43 | MAP3K13 | 1.10320792 |
| 44 | IRAK2 | 1.09683718 |
| 45 | SIK3 | 1.09133069 |
| 46 | BMX | 1.07299768 |
| 47 | JAK2 | 1.04702734 |
| 48 | TEC | 1.04576388 |
| 49 | MST1R | 1.03601317 |
| 50 | CHUK | 0.99857540 |
| 51 | CAMK1G | 0.98417538 |
| 52 | PAK4 | 0.97227285 |
| 53 | TRIB3 | 0.96424486 |
| 54 | ITK | 0.96313754 |
| 55 | MARK2 | 0.96298291 |
| 56 | TAOK2 | 0.89606507 |
| 57 | CDC42BPA | 0.89102589 |
| 58 | PTK6 | 0.88625243 |
| 59 | EGFR | 0.87856064 |
| 60 | PRKD2 | 0.87694949 |
| 61 | ACVR1B | 0.87050485 |
| 62 | RPS6KA4 | 0.86301554 |
| 63 | TTN | 0.85568603 |
| 64 | RIPK1 | 0.84855792 |
| 65 | CAMKK2 | 0.84489261 |
| 66 | MOS | 0.78687897 |
| 67 | PRKCD | 0.70245084 |
| 68 | ABL2 | 0.70111728 |
| 69 | MARK3 | 0.67246945 |
| 70 | PIM1 | 0.67024442 |
| 71 | NME2 | 0.66224869 |
| 72 | MAP3K3 | 0.65982405 |
| 73 | MAP3K6 | 0.65332162 |
| 74 | MAPK7 | 0.65108912 |
| 75 | MAP2K4 | 0.63824893 |
| 76 | PIM2 | 0.63718679 |
| 77 | ABL1 | 0.62789574 |
| 78 | GRK6 | 0.62688370 |
| 79 | MAP2K6 | 0.62184529 |
| 80 | CAMKK1 | 0.62079672 |
| 81 | FGFR4 | 0.60115849 |
| 82 | STK11 | 0.59539060 |
| 83 | SCYL2 | 0.57887642 |
| 84 | ADRBK2 | 0.57191800 |
| 85 | MAP3K7 | 0.56265511 |
| 86 | MAP3K11 | 0.55499797 |
| 87 | BMPR2 | 0.54582408 |
| 88 | MAP3K2 | 0.53505414 |
| 89 | PTK2B | 0.53341115 |
| 90 | LRRK2 | 0.52488081 |
| 91 | RPS6KA6 | 0.51805019 |
| 92 | TRPM7 | 0.50600577 |
| 93 | STK4 | 0.50154017 |
| 94 | SIK2 | 0.49691179 |
| 95 | MAP3K5 | 0.49689634 |
| 96 | FYN | 0.49277751 |
| 97 | FGFR3 | 0.48230170 |
| 98 | PRKCQ | 0.48102372 |
| 99 | TESK2 | 0.47784799 |
| 100 | SGK3 | 0.47054595 |
| 101 | KSR1 | 0.46939390 |
| 102 | CDK12 | 0.45968028 |
| 103 | FLT3 | 0.44786744 |
| 104 | CDK19 | 0.44198903 |
| 105 | RPS6KC1 | 0.43761190 |
| 106 | RPS6KL1 | 0.43761190 |
| 107 | MAPKAPK2 | 0.43261289 |
| 108 | PDPK1 | 0.42717434 |
| 109 | PRKG2 | 0.42256006 |
| 110 | IGF1R | 0.41945010 |
| 111 | PRKCH | 0.41890452 |
| 112 | PDK1 | 0.41439591 |
| 113 | CDK6 | 0.41151743 |
| 114 | YES1 | 0.41126640 |
| 115 | EIF2AK2 | 0.40352262 |
| 116 | ARAF | 0.37215986 |
| 117 | DAPK2 | 0.36927946 |
| 118 | SGK2 | 0.35850852 |
| 119 | DYRK1B | 0.34796124 |
| 120 | RPS6KA2 | 0.33334365 |
| 121 | HIPK2 | 0.32765445 |
| 122 | MAP3K1 | 0.32583716 |
| 123 | PRKCZ | 0.32166778 |
| 124 | RAF1 | 0.31056408 |
| 125 | EPHA3 | 0.29790161 |
| 126 | MAPK4 | 0.29188948 |
| 127 | ALK | 0.29016522 |
| 128 | ERBB3 | 0.28937999 |
| 129 | CAMK4 | 0.28493917 |
| 130 | KDR | 0.27342046 |
| 131 | MAPK12 | 0.26960203 |
| 132 | PIK3CG | 0.26196001 |
| 133 | INSR | 0.25897634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.11976943 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.48603063 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.34518864 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 3.16473342 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.10811531 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60377063 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.58467217 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.53032484 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.32840376 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.25109548 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.24923829 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.00881065 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92676867 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86891907 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.80570347 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.80327807 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77755721 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67437845 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.65330924 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65272426 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64681601 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64653974 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52725790 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48895447 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.47903584 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.47008286 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42811502 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39765077 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39625683 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36439278 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.34464260 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34097755 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32518415 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30924511 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30287277 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.28207739 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25862542 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21625235 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19352435 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.18850124 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.12643760 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12447584 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.07523695 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03287103 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02850643 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00282289 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98731222 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93375567 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92466916 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.92015361 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90415669 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89542432 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.89505088 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.83943273 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82105075 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72926753 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71704279 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69745116 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68896028 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.67795148 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67473407 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66289637 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66289514 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65619575 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63303384 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62877208 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.61855784 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60466964 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59631427 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56111485 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51523428 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50149167 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49327349 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49001149 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48934424 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47946333 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47350407 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46978894 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45649397 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45645268 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.43494748 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42961042 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.42894233 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41847478 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39898326 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39878529 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38355123 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37603963 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37398475 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36708770 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36156212 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35953156 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35929020 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35065603 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31996115 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30972672 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30867340 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30377525 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30066050 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29569260 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29274078 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29106637 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28666289 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28642177 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28296218 |
| 106 | * Mineral absorption_Homo sapiens_hsa04978 | 0.26390276 |
| 107 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.26363666 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25104632 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24062850 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.23409572 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21911180 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21458448 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20270663 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20157022 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19509983 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17495019 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17038363 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16717778 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.15302485 |

